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ABSTRACT   1 
Background Children born preterm or with a small-size-for-gestational-age are at increased 2 
risk for childhood asthma.  3 
Objective To assess the hypothesis that these associations are explained by reduced 4 
airway patency. 5 
Methods We used individual participant data of 24,938 children from 24 birth cohorts to 6 
examine and meta-analyze the associations of gestational age, size-for-gestational-age, and 7 
infant weight gain with childhood lung function and asthma (age range 3.9 – 19.1 years). 8 
Second, we explored whether these lung function outcomes mediated the associations of 9 
early growth characteristics with childhood asthma. 10 
Results Children born with a younger gestational age had a lower FEV1 (forced expiratory 11 
volume in 1 second), FEV1/FVC (FEV1/forced vital capacity), and FEF75 (forced expiratory 12 
volume after exhaling 75% of vital capacity), whereas those born with a smaller size-for-13 
gestational-age at birth had lower FEV1 but higher FEV1/FVC (p-values<0.05). Greater infant 14 
weight gain was associated with higher FEV1, but lower FEV1/FVC and FEF75 in childhood 15 
(p-values<0.05). All associations were present across the full range and independent  of 16 
other early life growth characteristics. Preterm birth, low birth weight and greater infant 17 
weight gain were associated with an increased risk of childhood asthma (pooled odds ratio 18 
(95% CI): 1.34 (1.15, 1.57), 1.32 (1.07, 1.62) and 1.27 (1.21, 1.34), respectively). Mediation 19 
analyses suggested that FEV1, FEV1/FVC and FEF75 may explain 7 (2, 10)% to 45 (15, 81)% 20 
of the associations between early growth characteristics and lung function. 21 
Conclusions Younger gestational age, smaller size-for-gestational-age, and greater infant 22 
weight gain were across the full ranges associated with childhood lung function. These 23 
associations explain to a substantial extent the risk of childhood asthma.  24 
 25 
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Capsule Summary 26 
Younger gestational age, smaller size-for-gestational-age at birth, and greater infant weight 27 
gain are independently and across the full ranges associated with lung function adaptations, 28 
and might explain 7-45% of the risk of childhood asthma. 29 
 30 
Clinical implications 31 
Early growth characteristics may persistently affect lung function, and thereby contribute to 32 
the risk of obstructive respiratory diseases in later life. 33 
 34 
Abbreviations 35 
FEV1  Forced expiratory volume in 1 second  36 
FVC  Forced vital capacity 37 
FEF25-75 Forced mid-expiratory flow 38 
FEF75  Forced expiratory flow after exhaling 75% of the vital capacity 39 
SDS  Standard deviation scores  40 
ATS/ERS American Thoracic Society / European Respiratory Society  41 
BMI  Body mass index42 
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INTRODUCTION 43 
Children born extremely preterm or with a low birth weight have high rates of neonatal 44 
respiratory diseases such as infant respiratory distress syndrome and bronchopulmonary 45 
dysplasia (1). An accumulating body of evidence suggests that these children also have an 46 
increased risk of chronic obstructive respiratory diseases in adulthood (2). More recent, 47 
prospective studies in children suggest that preterm birth and small size for gestational age 48 
at birth increase the risk of childhood asthma (3). Recent results of a meta-analysis of 49 
individual participant data of 147,000 children participating in prospective birth cohort studies 50 
showed consistent associations of younger gestational age at birth and greater infant weight 51 
gain with childhood asthma (4). The associations of lower birth weight with childhood asthma 52 
seem to be largely explained by gestational age at birth (4). The mechanisms underlying the 53 
associations of early growth characteristics with childhood asthma are not known yet. Airway 54 
caliber is a key determinant of total airway resistance. A reduced airway caliber could result 55 
in airway obstruction that predisposes to asthma and chronic obstructive pulmonary 56 
diseases (5-7). Therefore, we hypothesized that the associations of early growth 57 
characteristics with childhood asthma might be explained by  developmental adaptations of 58 
the lungs and airways, leading to relatively small airways and, hence, a reduction in 59 
expiratory flows reflected by lower lung function values (8). Thus far, previous studies 60 
focused on the associations of birth weight and infant weight gain with childhood lung 61 
function have reported inconsistent results (9-16). These inconsistent results might be due to 62 
the different ages at which spirometry was performed, and not taking other early growth 63 
characteristics or potential confounders into account. 64 
 To test the hypothesis that the associations of early life growth characteristics with 65 
childhood asthma are explained by reduced airway patency, we performed an individual 66 
participant data meta-analysis of 24,938 children from 24 birth cohort studies. We examined 67 
the strength, consistency, and independence of the associations of gestational age at birth, 68 
birth weight and infant weight gain with lung function outcomes in childhood and whether 69 
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these lung function outcomes explain the previously reported associations of early growth 70 
characteristics with risk of childhood asthma.  71 
 72 
METHODS  73 
 74 
Sources of data 75 
European population-based birth- and mother-child cohorts participated if they included 76 
children born between 1989 and 2011, had information available on at least gestational age 77 
and weight at birth and lung function measurements in childhood (until age 18 years), and 78 
were willing and able to exchange original data.(4) We identified 50 European cohorts 79 
selected from existing collaborations on childhood health or asthma-related outcomes 80 
(www.chicosproject.eu, www.birthcohortsenrieco.net, www.ga2len.org, 81 
and www.birthcohorts.net; accessed until May 29, 2012). In total, 24 cohorts, comprising 82 
data on 24,938 children, fulfilled the criteria (S-figure 1). 83 
 Information about gestational age and weight at birth and weight in the first year of 84 
life was obtained by measurements, medical registries or parental questionnaires (S-table 85 
1). We created gestational age-adjusted birth weight standard deviation scores (birth weight 86 
SDS) based on European reference values (17). Infant weight gain in the first year was 87 
defined as the difference between weight at age 1 year (range 6-18 months) and weight at 88 
birth, divided by the number of months between these two measurements. Standard 89 
deviation scores (SDS) for age-specific infant weight gain were derived by intra-cohort 90 
means and standard deviations (18). Cohort specific growth characteristics are given in the 91 
Supporting Information (S-table 2). 92 
All cohorts obtained lung function measurements by spirometry, of which 22 93 
according to the recent guidelines of the American Thoracic Society / European Respiratory 94 
Society (ATS/ERS) (19-21), and 2 according to earlier guidelines of the ATS (22) or ERS 95 
and European Coal and Steel Community (23) (S-table 1). If cohorts had collected lung 96 
function data at multiple time points (n = 6 cohorts), we used the measurement closest to the 97 
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mean age of children (8.5 years) in the full meta-analysis. Variables for analyses were 98 
forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), forced mid-99 
expiratory flow (FEF25–75) and forced expiratory flow after exhaling 75% of the vital capacity 100 
(FEF75). We mainly focused on FEV1, FEV1/FVC, and FEF75, which reflect reduced airway 101 
patency in obstructive lung diseases such as asthma or bronchopulmonary dysplasia due to 102 
preterm birth or low birth weight (24, 25). All lung function variables were converted into sex-103 
, height-, age-, and ethnicity (Caucasian versus non-Caucasian) -adjusted Z-scores based 104 
on the Global Lung Initiative reference values (26).  Asthma (yes / no) was defined as ever 105 
physician diagnosed asthma, and was obtained by medical registries (2 cohorts) or parental 106 
questionnaires adapted from the International Study on Asthma and Allergy in Childhood 107 
(ISAAC) (27) (22 cohorts)  at the age of spirometry (S-table1). Cohort specific 108 
characteristics of lung function measurements and asthma are given in the Supporting 109 
Information (S-table 3).  110 
We included covariates based on known associations with childhood lung function 111 
from previous studies (28, 29). Information on covariates was mainly assessed by 112 
questionnaires (S-table 1). Potential confounders included maternal educational level, 113 
smoking during pregnancy, smoking during infancy of their offspring, history of asthma or 114 
atopy, child’s sex, siblings, day care attendance in the first 2 years of life, breastfeeding, 115 
lower respiratory tract infections in the first 2 years of life, eczema, inhalant allergies, and 116 
body mass index (BMI) at the moment of lung function measurement. Cohort specific 117 
characteristics of all covariates are given in the Supporting Information (S-tables 4-5). 118 
 119 
Statistical analysis  120 
First, we conducted 1-stage random effect regression analyses to study the separate and 121 
combined associations of gestational age, birth weight and infant weight gain with FEV1, 122 
FVC, FEV1/FVC, FEF25-75 and FEF75. For these analyses, individual participant data from all 123 
cohorts were combined and modeled simultaneously taking into account clustering of 124 
participants within studies (30). To prevent multicollinearity in our regression models, we 125 
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initially assessed the separate associations of gestational age and birth weight with lung 126 
function. Thereafter, we assessed whether the associations of birth weight with lung function 127 
was driven by gestational age by creating gestational age adjusted birth weight standard 128 
deviation scores. The models focused on the associations of infant weight gain with lung 129 
function outcomes were adjusted for gestational age and weight at birth. For these analyses, 130 
we used early growth characteristics as continuous variables in the models providing p-131 
values for trend. To test non-linear and dose-response associations, we categorized 132 
gestational age, birth weight SDS and infant weight gain SDS. As a sensitivity analysis, we 133 
conducted a 2-stage random effect meta-analysis to study the associations of gestational 134 
age, birth weight, and infant weight gain, and dichotomized preterm birth and low birth 135 
weight with each lung function outcome. For this analysis, we used linear regression models 136 
per cohort, after which pooled regression coefficients (β’s) from the per cohort effect 137 
estimates were calculated. We tested for heterogeneity between effect estimates using I2 138 
(31, 32). For all analyses, the first model was adjusted for child’s sex (crude model), the 139 
second model was additionally adjusted for potential confounders (full model). To determine 140 
interactive effects between gestational age, birth weight and infant weight gain we added the 141 
corresponding multiplicative terms in the full model. Since we used Northern-European 142 
reference curves for birth weight SDS, we performed a sensitivity analysis to explore 143 
whether the associations were different in North-Western European subjects only. Numbers 144 
were too small to perform these analyses separately in other European regions. To assess 145 
differences in results related to pubertal growth changes, we repeated our analyses is strata 146 
of children aged < 11 years and ≥11 years (33). We also performed a complete-case 147 
sensitivity analysis to explore any differences between complete and non-complete-case 148 
analyses, and sensitivity analyses in which we excluded cohorts that used parental report of 149 
early growth characteristics or that did not perform spirometry measurements according to 150 
the ATS/ERS guidelines. 151 
Second, we conducted a 1-stage random effect regression analysis to assess the 152 
associations of early growth characteristics with asthma, and observed whether changes in 153 
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the effect estimates occurred after additional adjustment for lung function measures (FEV1, 154 
FVC, FEV1/FVC, FEF25-75 and FEF75 ) as potential mediators (mediator model). The 155 
difference between the original effect estimates and the effect estimates after additional 156 
adjustment for potential mediators was expressed as percentage change. The percentage 157 
change was calculated by the formula: 100 x (effect estimatemediator - effect estimateoriginal 158 
model)/( effect estimateoriginal model- 1). A 95% confidence interval for the percentage change of 159 
the effect estimate was calculated using a bootstrap method with 1,000 resamplings (34-36).  160 
For all analyses, missing values in covariates were used as an additional group in 161 
the categorical variables to prevent exclusion of non-complete cases. Statistical analyses 162 
were performed with R version 3.0.0 (libraries rmeta and metafor; The R foundation for 163 
Statistical Computing), and Comprehensive Meta-Analysis (Biostat, US).  164 
 165 
RESULTS  166 
 167 
Subject characteristics  168 
Information about the main characteristics of the cohorts are given in Table 1. Detailed 169 
information about determinants, outcomes and covariates is given in the Supporting 170 
Information (S-tables 1-5). Of all participants, 8.2% (n = 2,053) was born preterm (<37 171 
weeks of gestational age), and 4.8% (n = 1,191) was born with a low birth weight (<2,500 172 
gram). The mean age at which spirometry assessments were performed was 8.5 (range 3.9 173 
- 19.1) years. The proportion of children aged ≥11 years was 11.9% (n = 2,972). 174 
 175 
Early growth measures and lung function outcomes 176 
Results from the 1-stage random effect models showed that younger gestational age at birth 177 
was, across the full range, associated with lower FEV1, FEV1/FVC and FEF75 in childhood 178 
(p-values for trend <0.01) (Figures 1A-C). A smaller size-for-gestational-age at birth across 179 
the full range was associated with lower FEV1 and higher FEV1/FVC (p-values for trend 180 
<0.01) (Figures 1D-E). Small size-for-gestational-age at birth was not associated with FEF75 181 
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(Figure 1F). Greater infant weight gain was associated with a higher FEV1, but with a lower 182 
FEV1/FVC and FEF75 (p-values for trend <0.01; Figures 1G-I). Most associations showed a 183 
linear trend, except for the associations of birth weight with FEV1/FVC and infant weight gain 184 
with FEV1 and FEV1/FVC which were non-linear (Figures 1E, G, H). 185 
 To explore the combined effects of gestational age, birth weight SDS and infant 186 
weight gain SDS, we performed tests for interaction between these early growth 187 
characteristics. These tests for interaction were significant for gestational age and birth 188 
weight SDS in relation to FEV1, FEV1/FVC, FEF25-75 and FEF75 (p-values for interaction 189 
<0.01; Figure 2, S-table 9). Stratified analyses showed that a lower birth weight was 190 
associated with lower FEV1 and FEV1/FVC among children born after ≥ 32 weeks only, 191 
whereas higher birth weight was associated with FEF75 only among term born children (p-192 
values for strata <0.05).   193 
 No differences in results were observed when we used 2-stage random effect 194 
models of combined effect estimates (: S-tables 6-7). Also, the results from the sensitivity 195 
analyses showed similar results when we used cohorts with North-Western European 196 
subjects only, when we excluded cohorts that did not perform spirometry measurements 197 
according to the recent ATS/ERS guidelines, when we performed stratified analyses for 198 
children aged < 11 years or ≥ 11 years (S-table 8), or when we excluded cohorts that used 199 
parental report of early growth characteristics (data not shown).  200 
 Figure 3 shows that compared to term born children, those born preterm had a lower 201 
FEV1, FEV1/FVC and FEF75, (pooled Z-score (95% CI): -0.20 (-0.26, -0.14), -0.15 (-0.21, -202 
0.09) and -0.19 (-0.27, -0.11), respectively). Also, compared to normal birth weight children, 203 
those with a low birth weight had lower FEV1, FEV1/FVC and FEF75 (-0.29 (-0.38, -0.21) and 204 
-0.16 (-0.25, -0.08) and -0.17 (-0.26, -0.08) respectively), independent of gestational age. 205 
Results of associations of growth characteristics with all lung function outcomes, including 206 
FVC and FEF25-75 are given in the Supporting Information: S-tables 6-8.  207 
 208 
Early growth, lung function and asthma  209 
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Preterm birth, low birth weight and greater weight gain were all associated with an increased 210 
risk of childhood asthma (OR (95% CI): 1.34 (1.15, 1.57), 1.32 (1.07, 1.62) and 1.27 (1.21, 211 
1.34), respectively. Mediation analyses suggested that FEV1, FEV1/FVC and FEF75 may 212 
explain 7 (2, 10)% to 45 (15, 81)%. Specifically, after additional adjustment for FEV1, 213 
FEV1/FVC or FEF75, the associations of preterm birth with asthma attenuated with -7 (-19, -214 
1)%, -14 (-40, -3)% and -39 (-69, -3)%, respectively. Similarly, the associations of low birth 215 
weight with asthma attenuated with -19 (-37, -12)%, -22 (-47, -11)% and -222 (-47, -11)%, 216 
respectively (Table 2). The strongest mediating effect was observed for FEF75 for the 217 
association between gestational age and asthma (-45 (-81, -15)%). Similar trends were 218 
observed for greater weight gain, although the associations did not attenuate into non-219 
significant. 220 
 221 
DISCUSSION  222 
In this meta-analysis of individual participant data of 24,938 children from 24 birth cohorts, 223 
we observed that lower gestational age, smaller size at birth and greater infant weight gain 224 
were all associated with lower childhood FEV1. The positive associations of birth weight and 225 
infant weight gain with FVC were larger than of the positive associations of birth weight and 226 
infant weight gain with FEV1. This combination resulted in associations of higher birth weight 227 
and infant weight gain with lower FEV1/FVC. Also, a lower gestational age at birth was 228 
associated with a lower FEF75 in childhood, suggesting persistent reduction of small airways 229 
patency. A greater infant weight gain was associated with lower FEF75.. Remarkably, these 230 
associations were present across the full-range of early growth and not restricted to clinically 231 
diagnosed preterm- or low birth weight children. Also, the observed associations of the early 232 
life growth characteristics with lung function outcomes were independent of each other. 233 
Stratified analyses showed that children born very preterm with a relatively low birth weight 234 
had the lowest FEV1 and FEV1/FVC. The associations of early growth characteristics with 235 
childhood asthma were partly explained by lung function adaptations.  236 
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 Whereas lung growth continues until the early adulthood, the most rapid 237 
development of airways and alveoli occurs in early life (37). Developmental adaptations in 238 
fetal life and infancy due to early life adverse exposures might result in impaired lung growth 239 
with smaller airways, decreased lung volume, and subsequently to an increased risk of 240 
bronchopulmonary dysplasia, asthma or COPD (9, 14, 38). Previous studies suggest that 241 
children with asthma already have a reduced lung function in the first months of life, and that 242 
this deficit  progresses into childhood and early adulthood (39, 40). Airway caliber is a key 243 
determinant of total airway resistance and reduced caliber is a prominent feature of asthma 244 
and chronic obstructive pulmonary diseases (5-7). Lower lung function in early life is likely to 245 
lead to lower peak lung function in early adulthood, and the natural decline in FEV1 from that 246 
point onwards will be accelerated by any additional adverse exposures (41). Thus, lung 247 
function during the lifecourse seems to be programmed at least partly in early life.  248 
 Children born preterm or with a very low birth weight are at increased risk of neonatal 249 
respiratory diseases (1). We observed that children born at a younger gestational age had a 250 
lower FEV1, even after taking FVC into account, and a lower FEF75 in childhood. These 251 
associations were not only present among children born very preterm, but across the full 252 
range of gestational age at birth. Moreover, the associations of preterm birth with childhood 253 
asthma were partly explained by lung function. These findings are in line with previous 254 
studies showing persistent lung function adaptions in children and adults born preterm. A 255 
recent meta-analysis of 28 published studies showed that children born between 24 and 36 256 
weeks had a lower FEV1 at ages 5 up to 23 years (42). These and other studies suggest that 257 
preterm birth has adverse effects on lung function, persisting into adulthood (42-44).  258 
In the present study, a lower birth weight was associated with lower FEV1 in 259 
childhood. This suggests that a lower birth weight leads to a persistent reduction of airway 260 
patency. A previous study analyzed 10 studies examining the associations of birth weight 261 
with FEV1  in adults (range 19 – 70 years) (10). The authors reported a modest positive 262 
association between FEV1 and birth weight. Two recent studies from longitudinal birth 263 
cohorts among adults reported strong positive associations of birth weight with FEV1 and 264 
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FEF25-75 in young adults aged 21 and 31 years (9, 11). The effect of birth weight was 265 
independent of preterm birth in both studies. However, studies among children showed 266 
conflicting results (12, 13). We observed an association of lower birth weight with lower 267 
FEV1, independent of gestational age at birth. We previously reported that the effect of lower 268 
birth weight on asthma was largely explained by gestational age (4). Therefore, although 269 
gestational age-adjusted birth weight is associated with lower lung function this seems not 270 
related to the risk of clinically manifest childhood asthma.  271 
Previous studies examining associations between infant weight gain and childhood 272 
lung function have reported inconsistent results (14-16). Differences might be due to 273 
different ages at which spirometry was performed, not taking other weight characteristics 274 
into account, such as birth weight or current body mass index, and possible hidden bias due 275 
to the use of mL instead of Z-scores for lung function (45). In line with the findings for birth 276 
weight, we observed that lower infant weight gain was associated with a lower childhood 277 
FEV1 and FVC (p-value for continuous variables <0.001) Lower infant weight gain was 278 
associated with a less lower FEV1 than lower FVC which resulted in a higher FEV1/FVC.  279 
These results suggest dysanapsis, in which airways reflected by FEV1 remain relatively 280 
small in relation to total lung volume reflected by FVC, as a result of a mismatch between 281 
airway and alveolar growth (46). Greater infant weight gain was also associated with a lower 282 
FEF75, which is in line with previous studies reporting associations of body mass index or 283 
adiposity with reduced expiratory flows and asthma (47, 48). A suggested mechanism is 284 
leptin release from adipose tissue, which might have pro-inflammatory effects in the airways 285 
(49), or a direct effect of increased body weight on lung function (50). However, our analyses 286 
were adjusted for childhood body mass index. Further studies are needed to explore 287 
whether the associations of infant weight gain with end-expiratory flows are explained by 288 
specific adiposity-related measures or biomarkers.  289 
To the best of our knowledge this is the first study that examines the individual and 290 
combined associations of the main early growth characteristics with childhood lung function 291 
outcomes, and whether lung function adaptations explain the previously reported 292 
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associations of early growth characteristics with childhood asthma. Our results suggest that 293 
respiratory consequences of preterm birth and a low birth weight present across the full 294 
range. This observation might have important population effects, since the largest majority of 295 
children are in the less extreme ranges of gestational age and weight at birth. Furthermore, 296 
our results suggest that the associations of gestational age, birth weight and infant weight 297 
gain with childhood asthma are at least partly explained by adaptions in airway caliber. We 298 
observed strong effect estimates with wide confidence intervals which limits the precision. 299 
Therefore, these mediation effects should be interpreted carefully. The effect estimates for 300 
the observed associations could be considered as small and without clinical relevance for 301 
individuals. However, the associations may be important from an etiological respiratory 302 
developmental perspective and may be important on a population-level. The associations of 303 
early growth characteristics with lung function outcomes seemed already established before 304 
the pubertal growth spurt. The largest lung and airway growth occurs before pubertal growth 305 
spurt (37, 51), with FVC increasing proportionately more than the FEV1 (33). Lung and 306 
airway growth is proportionally less after start of the pubertal growth spurt (33), which might 307 
explain the similar effect estimates before and after the pubertal growth spurt. Further 308 
studies are needed to identify the developmental adaptations of the lungs and immune 309 
system that might explain the mediating effect of lung function on the associations of early 310 
growth characteristics with childhood asthma. Identification of modifiable exposures may 311 
lead to development of future preventive strategies.  312 
Some methodological limitations need to be discussed. We used data from 24 313 
ongoing cohort studies. Missing values always occur in these studies. Since we did not have 314 
additional data on patterns of missing values in all 24 cohorts, we were not able to perform 315 
multiple imputation. Data on childhood asthma was mainly obtained by parental 316 
questionnaires adapted from the International Study on Asthma and Allergy in Childhood 317 
(ISAAC) (27). This questionnaire has been validated in various age groups in many 318 
countries against measurements of bronchial hyperresponsiveness and doctor-diagnosed 319 
asthma, and is widely accepted in epidemiological studies. We did not have information on 320 
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use of asthma medication, which might have influenced the lung function values in asthmatic 321 
patients. This missing information on asthma medication may have influenced our effect 322 
estimates. We would expect that asthmatic children who use asthma medication would in 323 
general have had a higher lung function values in case of good adherence and inhaler 324 
technique. We used GLI reference data to convert lung function values into Z-scores. These 325 
prediction equations were based on 74,187 individuals including 31,840 individuals aged 326 
<20 years, of whom 58% were assessed before, and 42% were assessed during pubertal 327 
growth spurt (26). To date, the GLI normal values are considered the most accurate 328 
reference values for all age ranges, and have been adopted by both the ATS and ERS. For 329 
the covariates, we imputed missing values as additional category to prevent exclusion of 330 
non-complete cases. No differences in results were observed in complete case analyses. No 331 
direct clinical and laboratory information about pubertal growth was available.  Also, 332 
although we took major potential confounders into account, residual confounding may still be 333 
an issue. No information was available about e.g. exposure to environmental micro-334 
organisms or asthma severity. Exploring mediation of lung function for the association of 335 
early growth characteristics with asthma using the method proposed by Baron and Kenny 336 
might have been limited by misclassification of lung function measurements or asthma 337 
diagnosis although we aimed to reduce this issue by multi-level modelling (52). Most of the 338 
participating studies had measured childhood lung function and asthma at the same age. 339 
Therefore, further follow-up studies with longitudinally measured detailed data on lung 340 
function and asthma or related symptoms from birth onwards are needed to disentangle the 341 
direction of causality.  342 
 In conclusion, younger gestational age, lower birth weight and lower infant weight 343 
gain were independently associated with persistent changes in childhood lung function. 344 
These associations were present across the full spectrum of these early growth 345 
characteristics. Stratified analyses showed that children born very preterm with a relatively 346 
low birth weight had the lowest FEV1 and FEV1/FVC. Our results suggest that associations 347 
of early growth with the risk of childhood asthma were partly explained by lung function 348 
17 
 
adaptations. Thus, fetal and infant growth patterns may persistently affect lung function, and 349 
thereby contribute to the risk of respiratory diseases in later life.   350 
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 Figure 1. Associations of gestational age, birth weight and infant weight gain with FEV1, 
FEV1/FVC ratio and FEF75. 
 
Legend:  
Values represent Z-scores differences (95% confidence interval) from multi-level random 
effect models for the associations of gestational age at birth (A, B, C), gestational age 
adjusted birth weight (birth weight SDS) (D, E, F), and infant weight gain (SDS) (G, H, I) with 
lung function outcomes, compared with reference groups. Reference groups were 40-42.9 
weeks of gestational age, 0-0.99 birth weight SDS and 0.00 – 0.99 infant weight gain (SDS) 
(largest groups), and represented by an open bullet. Lung function outcomes are forced 
expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FVC) ratio, and forced 
expiratory flow at 75% of the exhaled FVC (FEF75). Models are adjusted for maternal 
education, smoking during pregnancy, smoking during childhood, atopy, asthma and child’s 
sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, 
childhood eczema, inhalant allergies and body mass index. Infant weight gain SDS was 
additionally adjusted for birth weight and gestational age at birth.  
 
Figure 2. Combined associations of gestational age and birth weight with FEV1, FEV1/FVC 
ratio and FEF75. 
 
Legend:  
Values are Z-score differences (95% confidence interval) from multi-level models for the 
combined associations of gestational age at birth and birth weight SDS (A, B, C) with lung 
function outcomes, compared with reference groups. Reference groups were >37 weeks of 
gestational age with  -1.00 to 0.99 birth weight SDS  (largest group), and represented by a 
bullet. Lung function outcomes are forced expiratory volume in 1 second (FEV1), 
FEV1/forced vital capacity (FVC) ratio, and forced expiratory flow at 75% of the exhaled FVC 
(FEF75). Models are adjusted for maternal education, smoking during pregnancy, smoking 
 during childhood, atopy, asthma and child’s sex, number of siblings, daycare attendance, 
breastfeeding, respiratory tract infections, childhood eczema, inhalant allergies and body 
mass index.  *P-value < 0.05. **P-value < 0.01. Given p-values reflect differences between 
birth weight SDS groups (A, B, C) within strata of gestational age using -1.00 to 0.99 birth 
weight SDS as reference group. Pint: p-values of multiplicative interaction terms. 
 
Figure 3. Forest plots of the associations between preterm birth and low birth weight with 
FEV1, FEV1/FVC ratio and FEF75.  
 
Legend: 
Values are pooled Z-score differences (95% confidence interval) from random effect meta-
analysis for the associations of preterm birth vs. term birth (A, B, C) and low birth weight vs. 
normal birth weight (D, E, F) with lung function outcomes. Lung function outcomes are 
forced expiratory volume in 1 second (FEV1), FEV1/forced vital capacity (FVC) ratio, and 
forced expiratory flow at 75% of the exhaled FVC (FEF75). Models are adjusted for maternal 
education, smoking during pregnancy, smoking during childhood, atopy, asthma and child’s 
sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, 
childhood eczema, inhalant allergies and body mass index. Low birth weight was adjusted 
for gestational age.  
 Table 1. Characteristics of participating cohorts. 
 
Cohort name 
(country) 
N 
Birth 
years 
Gestational 
age at birth 
(weeks) 
Birth 
weight 
(gram) 
FVC FEV1 
FEV1/ 
FVC 
FEF25-75 FEF75 
Childhood 
asthma 
 
 
 
Median 
(5-95% 
range) 
Mean (SD) Mean 
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Mean 
Z-score 
(SD) 
Yes 
ALSPAC  
(United Kingdom) 
6,873 
1991-
1992 
39.5 (1.9) 3,424 (543) 
0.49  
(1.28) 
0.44 
(1.17) 
-0.07 
(1.15) 
0.04 
(1.08) 
0.30 
(1.06) 
17.9 
(1,231) 
BAMSE 
(Sweden 
2,042 
1994-
1996  
39.9 (1.8) 3,537 (551)  
0.65 
(0.93) 
0.45 
(0.96) 
-0.37 
(0.89) 
- - 
14.8  
(303) 
BILD  
(Switzerland) 
159 
1999-
ongoing 
39.7 (1.3) 3,367 (441) 
-0.23  
(0.98) 
0.02 
(0.89) 
0.33 
(0.95) 
-0.06 
(0.87) 
- - 
CONER  
(Italy) 
217 
2004-
2005 
39.2 (1.4) 3,335 (457) 
-1.76 
(0.82) 
-1.04 
(0.90) 
0.51 
(1.65) 
0.45 
(1.00) 
- 
6.0  
(13) 
COPSAC2000  
(Denmark) 
314 
1998-
2001 
40.0 (1.6) 3,529 (531) 
-0.53 
(0.98) 
-0.11 
(1.03) 
0.47 
(0.95) 
- - 
18.8  
(59) 
EDEN  
(France) 
897 
2003-
2005 
39.3 (1.7) 3,284 (514) 
-1.08 
(1.05) 
-0.77 
(1.03) 
0.21 
(0.97) 
-0.39 
(1.01) 
0.16 
(0.88) 
18.1  
(162) 
GASPII  
(Italy) 
453 
2003-
2004 
39.2 (1.8) 3,314 (530) 
0.06 
(0.76) 
-0.01 
(0.88) 
-0.15 
(0.97) 
-0.30 
(0.90) 
- 
6.6 
(30) 
GENERATION R  
(The Netherlands) 
1,927 
2002-
2006 
39.7 (1.9) 3,392 (576) 
0.23 
(0.92) 
0.15 
(0.95) 
-0.19 
(0.92) 
0.15 
(1.05) 
-0.09 
(0.89) 
5.5  
(106) 
GENERATION XXI  
(Portugal) 
1,562 
2005-
2006 
38.4 (2.1) 3,152 (551) 
0.41 
(0.95) 
0.59 
(0.98) 
0.21 
(0.82) 
0.12 
(0.85) 
0.44 
(0.80) 
6.5  
(102) 
GINI 
(Germany) 
707 
1995-
1998 
- 3,493 (479) - 
0.02 
(0.92) 
- - - 
5.9 
(49) 
INMA Gipuzkoa 
(Spain) 
277 
2006-
2008 
39.7 (1.4) 3,284 (436) 
-0.54 
(1.16) 
-0.59 
(1.17) 
-0.05 
(0.91) 
-0.45 
(0.99) 
-0.16 
(1.00) 
5.4  
(15) 
INMA Menorca  
(Spain) 
367 
1997-
1998 
39.2 (1.8) 3,200 (493) 
0.01 
(1.13) 
-0.16 
(1.07) 
-0.24 
(1.19) 
-0.42 
(1.29) 
-0.06 
(1.32) 
4.9 
(18) 
  
 Table 1 (continued). Characteristics of participating cohorts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cohort name 
(country) 
N 
Birth 
years 
Gestational 
age at birth 
(weeks) 
Birth 
weight 
(gram) 
FVC FEV1 
FEV1/ 
FVC 
FEF25-75 FEF75 
Childhood 
asthma 
   
Median 
(5-95% 
range) 
Mean (SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Mean  
Z-score 
(SD) 
Yes 
INMA Sabadell  
(Spain) 
408 
2004-
2007 
39.8 (1.3) 3,261 (404) 
-0.47 
(1.38) 
-0.57 
(1.30) 
-0.08 
(1.03) 
-0.61 
(1.00) 
-0.25 
(1.12) 
0.7 
(3) 
INMA Valencia  
(Spain) 
455 
2003-
2005 
39.6 (1.7) 3,227 (491) 
0.30 
(1.10) 
0.30 
(1.08) 
-0.04 
(0.95) 
-0.13 
(0.91) 
-0.04 
(0.90) 
- 
ISLE OF WIGHT  
(United Kingdom) 
1,030 
1989-
1990 
39.9 (1.5) 3,411 (510) 
0.24 
(0.91) 
0.39 
(1.01) 
0.22 
(1.03) 
0.04 
(0.99) 
- 
21.5  
(221) 
KOALA  
(The 
Netherlands) 
438 
2000-
2003 
40.0 (1.2) 3,552 (467) 
0.15 
(0.94) 
-0.13 
(0.95) 
-0.55 
(0.84) 
- - 
8.0 
(35) 
LEICESTER 
1990  
(United Kingdom) 
290 
1985-
1990 
39.0 (2.2) 3,373 (599) 
-0.33 
(1.11) 
-0.38 
(1.12) 
-0.76 
(0.90) 
-0.62 
(1.01) 
- 
37.2  
(108) 
LEICESTER 
1998  
(United Kingdom) 
1,476 
1993-
1997 
39.2 (2.0) 3,314 (592) 
-0.41 
(1.04) 
-0.39 
(1.05) 
0.01 
(1.03) 
- 
0.05 
(0.94) 
36.4  
(538) 
MAS 
(Germany) 
641 1990 40.0 (1.4) 3,414 (460) 
-0.06 
(0.97) 
0.24 
(1.00) 
0.41 
(1.00) 
1.15 
(0.14) 
- 
5.0 
(32) 
PIAMA  
(The 
Netherlands) 
1,767 
1996-
1997 
39.9 (1.7) 3,526 (540) 
0.04 
(0.95) 
0.07 
(1.04) 
-0.04 
(1.01) 
-1.67 
(1.21) 
-0.21 
(0.95) 
10.0  
(176) 
RHEA  
(Greece) 
666 
2007-
2008 
38.1 (1.7) 3,175 (506) 
-0.25 
(1.09) 
-0.33 
(1.14) 
-0.10 
(0.94) 
-0.38 
(0.96) 
-0.17 
(1.05) 
5.9 
(39) 
SEATON  
(United Kingdom) 
578 1997 39.5 (1.8) 3,488 (563) 
-0.12 
(1.08) 
-0.06 
(1.08) 
-0.04 
(0.96) 
-0.27 
(0.98) 
- 
20.1  
(116) 
SWS 
(United Kingdom) 
803 
1998-
2007 
39.7 (1.9) 3,447 (548) 
0.13 
(1.01) 
0.03 
(0.95) 
-0.18 
(1.05) 
-0.28 
(0.94) 
- 
15.1  
(121) 
WHISTLER  
(The 
Netherlands) 
591 
2001-
2012 
40.0 (1.3) 3,553 (499) 
0.16 
(1.11) 
0.46 
(1.14) 
0.31 
(0.93) 
-0.04 
(1.23) 
0.12 
(1.07) 
9.3  
(55) 
 N = number of participants with information on at least gestational age or birth weight, and a lung function outcome. Lung function outcomes are forced vital 
capacity (FVC), force expiratory volume in 1 second (FEV1), mid forced expiratory flow (FEF25-75) and force expiratory flow at 75% of the exhaled FVC 
(FEF75). Values are means (standard deviations) and percentages (absolute numbers) for the information on asthma. Additional information on data collection 
(Table S1), determinants (Table S2), outcomes (Table S3), and maternal and child related covariates (Tables S4, S5)  is provided in the Supporting 
Information.
 Table 2. Associations of birth weight, gestational age and infant weight gain with childhood asthma, additionally adjusted for lung function. 
*p<0.05 **p<0.01. Values are odds ratios or percentage change in odds ratios (95% confidence interval) from random effect models and represent the risk of asthma per week, 
500 grams or SDS increase in gestational age, birth weight, gestational age adjusted birth weight (birth weight SDS), or infant weight gain (SDS), respectively, or represent 
odds ratios or percentage change in odds ratios (95% confidence interval) in risk of asthma for preterm birth vs. term birth, low birth weight vs. normal birth weight or small for 
gestational age vs. normal and large for gestational age (<10
th
 percentile vs >10
th
 percentile). Percentage  change in odds ratio (OR) is calculated using the formula (100 x 
(ORmediator - ORmodel 1)/(ORmodel 1 - 1)), with corresponding 95% confidence interval obtained by bootstrap procedures. To enable comparison of effect estimates, results for 
gestational age adjusted birth weight and infant weight gain are presented as per SDS. Models are adjusted for maternal education, smoking during pregnancy, smoking during 
childhood, atopy, asthma and child’s sex, number of siblings, daycare attendance, breastfeeding, respiratory tract infections, childhood eczema, inhalant allergies and body 
mass index (full model), and additionally for lung function outcomes (mediator model). 
 
 
 Risk of childhood asthma 
Odds ratio (95% Confidence Interval) 
  
Full model 
Full model  
+ FEV1 
% change 
(95% CI) 
Full model  
+ FEV1/FVC 
% change 
(95% CI) 
Full model  
+ FEF75 
% change 
(95% CI) 
        
Gestational age (weeks) 0.94  
(0.92, 0.97)** 
n = 15,019 
 
0.95  
(0.93, 0.97)** 
n = 14,832 
-9.8% 
(- 16.4, - 5.3)** 
0.95  
(0.93, 0.97)** 
n = 14,017 
-13.5%  
(-21.0, -7.3)** 
0.97  
(0.94, 1.00) 
n = 9,177 
-44.6% 
(-81.1, -14.6)** 
Preterm birth (<37 weeks) 1.34  
(1.15, 1.57)** 
n = 15,019 
1.30  
(1.11, 1.53)** 
n = 14,832 
-7.3%  
(-18.8, -0.9)* 
1.27  
(1.08, 1.49)** 
n = 14,017 
-14.4% 
(-39.6, -2.8)* 
1.20  
(0.99, 1.47)  
n = 9,177 
-39.0% 
(-69.3, -3.4)* 
Birth weight (500 grams) 0.94  
(0.90, 0.97)** 
n = 15,547 
 
0.95  
(0.91, 0.99)* 
n = 15,360 
-18.9%  
(-37.0, -11.2)** 
0.94  
(0.90, 0.98)** 
n = 13,985 
-10.5%  
(-21.9, -3.4)** 
0.96  
(0.92, 1.02) 
n = 9,135 
-17.8 
(-50.6, -9.0)** 
Low birth weight (<2,500 grams) 1.32  
(1.07, 1.62)** 
n = 15,547 
 
 
1.25  
(1.02, 1.54)* 
n = 15,360 
-19.0%  
(-37.3, -11.8)** 
1.23  
(0.99, 1.52) 
n = 13,985 
-21.6%  
(-47.3, -11.4)** 
1.05  
(0.81, 1.36)  
n = 9,135 
-82.5% 
(-149, 10.3) 
Birth weight (SDS)  0.98  
(0.94, 1.03) 
n = 14,947 
1.00  
(0.96, 1.05) 
n = 14,760 
-83.8% 
(-950, 825) 
0.98  
(0.94, 1.03) 
n =13,946 
-14.0% 
(-247, 281) 
0.99  
(0.93, 1.04) 
n = 9,122 
-15.8% 
(-158, 169) 
Small for gestational age (<10th percentile) 1.18  
(1.01, 1.37)* 
n = 14,947 
 
1.13  
(0.97, 1.32) 
n = 14,760 
-28.9% 
(-253, 108) 
1.16  
(0.99, 1.36) 
n = 13,946 
-18.8% 
(-123, 164) 
1.20  
(1.00, 1.44) 
n = 9,122 
10.2% 
(-8.3, 26.2) 
Infant weight gain in first year (SDS), 
adjusted for gestational age and weight at birth 
1.27  
(1.21, 1.34)** 
n = 12,511 
 
1.28  
(1.22, 1.35)** 
n = 12,511 
6.5% 
(2.3, 9.9)**  
1.25  
(1.18, 1.31)** 
n = 11,780 
-8.4%  
(-16.1, -3.2)** 
1.13  
(1.06, 1.20)** 
n = 7,969 
-60.8 
(-115, 39.5) 
  
